Hemoglobinopathies Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1552914 No. of Pages: 65 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.
This report aims to provide a comprehensive presentation of the global market for Hemoglobinopathies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoglobinopathies. This report contains market size and forecasts of Hemoglobinopathies in global, including the following market information:
Global Hemoglobinopathies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hemoglobinopathies market was valued at US$ 282.5 million in 2022 and is projected to reach US$ 379.4 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemoglobinopathies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemoglobinopathies Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathies Market Segment Percentages, by Type, 2022 (%)
Blood Transfusion
Iron Chelation Therapy
Bone Marrow Transplant
Others
Global Hemoglobinopathies Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathies Market Segment Percentages, by Application, 2022 (%)
Blood Testing
Genetic Testing
Pre-Implantation Genetic Diagnosis (PGD)
Others
Global Hemoglobinopathies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hemoglobinopathies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemoglobinopathies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hemoglobinopathies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gamida Cell
Alnylam Pharmaceuticals
Sanofi
Sangamo Therapeutics Inc.
Global Blood Therapeutics
Bluebird Bio
Emmaus Life Sciences Inc.
Prolong Pharmaceuticals
Celgene Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemoglobinopathies, market overview.
Chapter 2: Global Hemoglobinopathies market size in revenue.
Chapter 3: Detailed analysis of Hemoglobinopathies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemoglobinopathies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hemoglobinopathies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemoglobinopathies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemoglobinopathies Overall Market Size
2.1 Global Hemoglobinopathies Market Size: 2022 VS 2029
2.2 Global Hemoglobinopathies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemoglobinopathies Players in Global Market
3.2 Top Global Hemoglobinopathies Companies Ranked by Revenue
3.3 Global Hemoglobinopathies Revenue by Companies
3.4 Top 3 and Top 5 Hemoglobinopathies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hemoglobinopathies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemoglobinopathies Players in Global Market
3.6.1 List of Global Tier 1 Hemoglobinopathies Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemoglobinopathies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hemoglobinopathies Market Size Markets, 2022 & 2029
4.1.2 Blood Transfusion
4.1.3 Iron Chelation Therapy
4.1.4 Bone Marrow Transplant
4.1.5 Others
4.2 By Type - Global Hemoglobinopathies Revenue & Forecasts
4.2.1 By Type - Global Hemoglobinopathies Revenue, 2018-2023
4.2.2 By Type - Global Hemoglobinopathies Revenue, 2024-2029
4.2.3 By Type - Global Hemoglobinopathies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hemoglobinopathies Market Size, 2022 & 2029
5.1.2 Blood Testing
5.1.3 Genetic Testing
5.1.4 Pre-Implantation Genetic Diagnosis (PGD)
5.1.5 Others
5.2 By Application - Global Hemoglobinopathies Revenue & Forecasts
5.2.1 By Application - Global Hemoglobinopathies Revenue, 2018-2023
5.2.2 By Application - Global Hemoglobinopathies Revenue, 2024-2029
5.2.3 By Application - Global Hemoglobinopathies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hemoglobinopathies Market Size, 2022 & 2029
6.2 By Region - Global Hemoglobinopathies Revenue & Forecasts
6.2.1 By Region - Global Hemoglobinopathies Revenue, 2018-2023
6.2.2 By Region - Global Hemoglobinopathies Revenue, 2024-2029
6.2.3 By Region - Global Hemoglobinopathies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hemoglobinopathies Revenue, 2018-2029
6.3.2 US Hemoglobinopathies Market Size, 2018-2029
6.3.3 Canada Hemoglobinopathies Market Size, 2018-2029
6.3.4 Mexico Hemoglobinopathies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hemoglobinopathies Revenue, 2018-2029
6.4.2 Germany Hemoglobinopathies Market Size, 2018-2029
6.4.3 France Hemoglobinopathies Market Size, 2018-2029
6.4.4 U.K. Hemoglobinopathies Market Size, 2018-2029
6.4.5 Italy Hemoglobinopathies Market Size, 2018-2029
6.4.6 Russia Hemoglobinopathies Market Size, 2018-2029
6.4.7 Nordic Countries Hemoglobinopathies Market Size, 2018-2029
6.4.8 Benelux Hemoglobinopathies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hemoglobinopathies Revenue, 2018-2029
6.5.2 China Hemoglobinopathies Market Size, 2018-2029
6.5.3 Japan Hemoglobinopathies Market Size, 2018-2029
6.5.4 South Korea Hemoglobinopathies Market Size, 2018-2029
6.5.5 Southeast Asia Hemoglobinopathies Market Size, 2018-2029
6.5.6 India Hemoglobinopathies Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hemoglobinopathies Revenue, 2018-2029
6.6.2 Brazil Hemoglobinopathies Market Size, 2018-2029
6.6.3 Argentina Hemoglobinopathies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hemoglobinopathies Revenue, 2018-2029
6.7.2 Turkey Hemoglobinopathies Market Size, 2018-2029
6.7.3 Israel Hemoglobinopathies Market Size, 2018-2029
6.7.4 Saudi Arabia Hemoglobinopathies Market Size, 2018-2029
6.7.5 UAE Hemoglobinopathies Market Size, 2018-2029
7 Hemoglobinopathies Companies Profiles
7.1 Gamida Cell
7.1.1 Gamida Cell Company Summary
7.1.2 Gamida Cell Business Overview
7.1.3 Gamida Cell Hemoglobinopathies Major Product Offerings
7.1.4 Gamida Cell Hemoglobinopathies Revenue in Global Market (2018-2023)
7.1.5 Gamida Cell Key News & Latest Developments
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Company Summary
7.2.2 Alnylam Pharmaceuticals Business Overview
7.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Hemoglobinopathies Revenue in Global Market (2018-2023)
7.2.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hemoglobinopathies Major Product Offerings
7.3.4 Sanofi Hemoglobinopathies Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Sangamo Therapeutics Inc.
7.4.1 Sangamo Therapeutics Inc. Company Summary
7.4.2 Sangamo Therapeutics Inc. Business Overview
7.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Major Product Offerings
7.4.4 Sangamo Therapeutics Inc. Hemoglobinopathies Revenue in Global Market (2018-2023)
7.4.5 Sangamo Therapeutics Inc. Key News & Latest Developments
7.5 Global Blood Therapeutics
7.5.1 Global Blood Therapeutics Company Summary
7.5.2 Global Blood Therapeutics Business Overview
7.5.3 Global Blood Therapeutics Hemoglobinopathies Major Product Offerings
7.5.4 Global Blood Therapeutics Hemoglobinopathies Revenue in Global Market (2018-2023)
7.5.5 Global Blood Therapeutics Key News & Latest Developments
7.6 Bluebird Bio
7.6.1 Bluebird Bio Company Summary
7.6.2 Bluebird Bio Business Overview
7.6.3 Bluebird Bio Hemoglobinopathies Major Product Offerings
7.6.4 Bluebird Bio Hemoglobinopathies Revenue in Global Market (2018-2023)
7.6.5 Bluebird Bio Key News & Latest Developments
7.7 Emmaus Life Sciences Inc.
7.7.1 Emmaus Life Sciences Inc. Company Summary
7.7.2 Emmaus Life Sciences Inc. Business Overview
7.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Major Product Offerings
7.7.4 Emmaus Life Sciences Inc. Hemoglobinopathies Revenue in Global Market (2018-2023)
7.7.5 Emmaus Life Sciences Inc. Key News & Latest Developments
7.8 Prolong Pharmaceuticals
7.8.1 Prolong Pharmaceuticals Company Summary
7.8.2 Prolong Pharmaceuticals Business Overview
7.8.3 Prolong Pharmaceuticals Hemoglobinopathies Major Product Offerings
7.8.4 Prolong Pharmaceuticals Hemoglobinopathies Revenue in Global Market (2018-2023)
7.8.5 Prolong Pharmaceuticals Key News & Latest Developments
7.9 Celgene Corporation
7.9.1 Celgene Corporation Company Summary
7.9.2 Celgene Corporation Business Overview
7.9.3 Celgene Corporation Hemoglobinopathies Major Product Offerings
7.9.4 Celgene Corporation Hemoglobinopathies Revenue in Global Market (2018-2023)
7.9.5 Celgene Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com